BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15343586)

  • 1. Increasing of oxidative stress from mitochondria in type 2 diabetic patients.
    Nakanishi S; Suzuki G; Kusunoki Y; Yamane K; Egusa G; Kohno N
    Diabetes Metab Res Rev; 2004; 20(5):399-404. PubMed ID: 15343586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells from type 2 diabetic patients.
    García-Ramírez M; Francisco G; García-Arumí E; Hernández C; Martínez R; Andreu AL; Simó R
    Diabetes Metab; 2008 Apr; 34(2):117-24. PubMed ID: 18291700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
    Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
    J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
    Singhania N; Puri D; Madhu SV; Sharma SB
    QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
    Pan HZ; Zhang H; Chang D; Li H; Sui H
    Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
    Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
    Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD
    Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy.
    Ogawa S; Mori T; Nako K; Ito S
    Hypertens Res; 2008 Jun; 31(6):1147-55. PubMed ID: 18716362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
    Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
    Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid peroxidation in early type 1 diabetes mellitus is unassociated with oxidative damage to DNA.
    Hoeldtke RD; Bryner KD; Corum LL; Hobbs GR; Van Dyke K
    Metabolism; 2009 May; 58(5):731-4. PubMed ID: 19375599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.
    Ohshiro Y; Ma RC; Yasuda Y; Hiraoka-Yamamoto J; Clermont AC; Isshiki K; Yagi K; Arikawa E; Kern TS; King GL
    Diabetes; 2006 Nov; 55(11):3112-20. PubMed ID: 17065350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
    Kanwar M; Chan PS; Kern TS; Kowluru RA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
    De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
    Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression.
    Szuster-Ciesielska A; Słotwińska M; Stachura A; Marmurowska-Michałowska H; Dubas-Slemp H; Bojarska-Junak A; Kandefer-Szerszeń M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):686-94. PubMed ID: 18083280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus.
    Ferderbar S; Pereira EC; Apolinário E; Bertolami MC; Faludi A; Monte O; Calliari LE; Sales JE; Gagliardi AR; Xavier HT; Abdalla DS
    Diabetes Metab Res Rev; 2007 Jan; 23(1):35-42. PubMed ID: 16634125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.
    Koike N; Takamura T; Kaneko S
    Life Sci; 2007 Apr; 80(18):1721-8. PubMed ID: 17346751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus.
    Dursun E; Dursun B; Suleymanlar G; Ozben T
    Acta Diabetol; 2005 Oct; 42(3):123-8. PubMed ID: 16258735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
    Dave GS; Kalia K
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxidative-antioxidative balance disturbance and risk factors as well as vascular complications in patients with diabetes type 2].
    Knapik-Kordecka M; Piwowar A; Warwas M
    Wiad Lek; 2007; 60(7-8):329-34. PubMed ID: 18175551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.